Table of Content

  1. INTRODUCTION
    1. Study Assumptions and Market Definition
    2. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. Rapid Advancements in AI Technology & Need to Accelerate the Drug Development Process
    3. Market Restraints
      1. Data Privacy and Security Concerns
      2. High Implementation Costs
    4. Market Opportunity
      1. Focus on Developing Human-Aware AI Systems
    5. Market Trends
      1. Integration of AI with Cloud-Based Genomics Platforms
      2. Expansion of AI in Personalized Genomics
  5. MARKET SEGMENTATION
    1. By Component
      1. Hardware
      2. Software
      3. Services
    2. By Technology
      1. Machine Learning
        1. Deep Learning
        2. Supervised Learning
        3. Unsupervised Learning
        4. Others
      2. Computer Vision
    3. By Functionality
      1. Genome Sequencing
      2. Gene Editing
      3. Others
    4. By Application
      1. Drug Discovery & Development
      2. Precision Medicine
      3. Diagnostics
      4. Others
    5. By End-use
      1. Pharmaceutical and Biotech Companies
      2. Healthcare Providers
      3. Research Centers
      4. Others
    6. By Key Geographic Regions
      1. North America
        1. United States
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profile
      1. BenevolentAI
      2. IBM
      3. DEEP GENOMICS
      4. Data4Cure, Inc.
      5. Fabric Genomics
      6. Freenome Holdings, Inc.
      7. Illumina, Inc.
      8. Microsoft Corporation
      9. NVIDIA Corporation
      10. Thermo Fisher Scientific
      11. SOPHiA GENETICS
  7. MARKET OPPORTUNITIES AND FUTURE TREND



Frequently Asked Questions

Q.1. What is the projected market value of the global AI in Genomicsmarket?

The global market of AI in Genomics is projected to reach USD8Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global AI in Genomicsmarket?

The global AI in Genomics market has an estimated annual growth rate of 32.0%.

Q.3. What are the recent trends of AI in Genomicsmarket?

Integration of AI with cloud-based genomics platformsand expansion of AI in personalized genomics are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in AI in Genomics?

The major companies profiled in this report include BenevolentAI, IBM, DEEP GENOMICS, Data4Cure, Inc., Fabric Genomics, Freenome Holdings, Inc., Illumina, Inc., Microsoft Corporation, NVIDIA Corporation, Thermo Fisher Scientific, SOPHiA GENETICS, among others.   

Q.5. Which is the largest regional market in the AI in Genomics?

North America is the largest regional market for AI in Genomics.

Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.